Sartorius (OTCMKTS:SARTF) Sets New 1-Year High – Time to Buy?

Sartorius (OTCMKTS:SARTF – Get Free Report)’s share price reached a new 52-week high during mid-day trading on Friday. The stock traded as high as $261.9850 and last traded at $261.9850, with a volume of 1 shares traded. The stock had previously closed at $227.16.

Sartorius Trading Up 15.3%

The company has a market capitalization of $8.97 billion, a P/E ratio of 121.85 and a beta of 0.98. The company has a debt-to-equity ratio of 0.89, a current ratio of 0.95 and a quick ratio of 0.49. The firm has a fifty day moving average price of $230.79 and a 200-day moving average price of $222.00.

Sartorius Company Profile

(Get Free Report)

Sartorius AG is a Germany-based life science company that develops and supplies equipment, technologies and services used in research, pharmaceutical development and biopharmaceutical manufacturing. Its offerings support laboratories and production facilities across the development cycle, from early-stage research and process development to commercial-scale manufacturing.

The company operates through its Lab Products & Services and Bioprocess Solutions divisions. Its products and services include laboratory instruments, balances, consumables, analytical systems, filtration technologies, bioreactors, cell culture equipment, single-use manufacturing components, software and related services.

See Also

Receive News & Ratings for Sartorius Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sartorius and related companies with MarketBeat.com's FREE daily email newsletter.